• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?目前推荐的预防乙型肝炎病毒母婴传播的母体抗病毒预防措施是否需要加强？
JHEP Rep. 2023 Jun 29;5(11):100831. doi: 10.1016/j.jhepr.2023.100831. eCollection 2023 Nov.
2
Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?".回复：“目前推荐的预防乙型肝炎病毒母婴传播的母体抗病毒预防措施是否需要加强？”
JHEP Rep. 2023 Aug 7;5(11):100875. doi: 10.1016/j.jhepr.2023.100875. eCollection 2023 Nov.
3
Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.乙型肝炎母婴传播发生率与围产期母亲抗病毒预防的关系：系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1197-1206. doi: 10.1111/aogs.14448. Epub 2022 Sep 9.
4
Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.母体乙肝 e 抗原可作为乙肝病毒母婴传播的抗病毒预防指标。
Emerg Microbes Infect. 2021 Dec;10(1):555-564. doi: 10.1080/22221751.2021.1899055.
5
The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.资源有限环境下，母婴病毒临界值对预防围生期乙型肝炎病毒传播的抗病毒作用：中国一项大型前瞻性队列研究。
Vaccine. 2017 Dec 4;35(48 Pt B):6627-6633. doi: 10.1016/j.vaccine.2017.10.032. Epub 2017 Nov 1.
6
Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.纳米比亚乙型肝炎母婴传播预防：成本效益分析。
Vaccine. 2021 May 27;39(23):3141-3151. doi: 10.1016/j.vaccine.2021.04.041. Epub 2021 May 4.
7
Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.在免疫预防延迟的情况下，母亲进行抗病毒治疗可保护婴儿免受乙型肝炎传播。
Liver Int. 2020 Oct;40(10):2377-2384. doi: 10.1111/liv.14479. Epub 2020 Jun 30.
8
Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.乙型肝炎母婴传播：病毒学界值、HBsAg 血清学和婴儿检测的研究。
Liver Int. 2018 Jul;38(7):1212-1219. doi: 10.1111/liv.13736. Epub 2018 Mar 31.
9
Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications.乙型肝炎母婴传播预防的当前进展及其临床和规划意义。
Infect Drug Resist. 2019 Apr 26;12:977-987. doi: 10.2147/IDR.S171695. eCollection 2019.
10
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.抗病毒预防治疗在妊娠期间预防乙型肝炎病毒母婴传播的疗效和安全性：系统评价和荟萃分析。
Lancet Infect Dis. 2021 Jan;21(1):70-84. doi: 10.1016/S1473-3099(20)30586-7. Epub 2020 Aug 14.

引用本文的文献

1
Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?".回复：“目前推荐的预防乙型肝炎病毒母婴传播的母体抗病毒预防措施是否需要加强？”
JHEP Rep. 2023 Aug 7;5(11):100875. doi: 10.1016/j.jhepr.2023.100875. eCollection 2023 Nov.

本文引用的文献

1
Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus.加强预防乙型肝炎病毒母婴传播的干预措施。
JHEP Rep. 2023 Apr 24;5(8):100777. doi: 10.1016/j.jhepr.2023.100777. eCollection 2023 Aug.
2
Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.富马酸替诺福韦二吡呋酯或替比夫定在整个孕期使用预防乙型肝炎病毒母婴传播的疗效和安全性：一项队列研究。
Eur J Obstet Gynecol Reprod Biol. 2022 Sep;276:102-106. doi: 10.1016/j.ejogrb.2022.07.009. Epub 2022 Jul 14.
3
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.肯尼亚妊娠期间接受抗逆转录病毒治疗的 HIV 感染妇女不良妊娠结局的预测因素。
AIDS. 2022 Jun 1;36(7):1007-1019. doi: 10.1097/QAD.0000000000003215. Epub 2022 Mar 4.
4
Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus.从孕前开始进行连续抗病毒治疗以预防乙型肝炎病毒母婴传播的疗效和安全性。
Sci Rep. 2020 Aug 12;10(1):13631. doi: 10.1038/s41598-020-70644-4.
5
Congenital biliary atresia in an infant born to hepatitis B mother treated with telbivudine before and during pregnancy.一名在孕期及孕前接受替比夫定治疗的乙肝母亲所生婴儿患先天性胆道闭锁。
Dig Liver Dis. 2018 Oct;50(10):1097-1098. doi: 10.1016/j.dld.2018.07.030. Epub 2018 Aug 1.
6
Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.在慢性乙型肝炎活动期孕妇的早孕中开始使用拉米夫定或替比夫定的安全性和有效性。
Hepatol Int. 2018 Mar;12(2):118-125. doi: 10.1007/s12072-017-9839-5. Epub 2018 Jan 17.
7
Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study.替比夫定在妊娠晚期预防乙型肝炎病毒母婴传播的安全性和有效性：一项多中心前瞻性队列研究。
J Viral Hepat. 2018 Apr;25(4):429-437. doi: 10.1111/jvh.12834. Epub 2017 Dec 26.
8
Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.替比夫定对妊娠中期或晚期接受治疗的母亲所生婴儿的长期安全性和疗效
J Viral Hepat. 2017 Jun;24(6):514-521. doi: 10.1111/jvh.12670. Epub 2017 Feb 14.
9
Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.孕中期与孕晚期使用拉米夫定预防慢性乙型肝炎母婴传播的研究
J Viral Hepat. 2017 Mar;24(3):246-252. doi: 10.1111/jvh.12640. Epub 2016 Dec 26.
10
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.替诺福韦预防高病毒载量母亲乙肝母婴传播。
N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.

Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?

作者信息

Zhou Yi-Hua, Zhao Hong

机构信息

Departments of Laboratory Medicine and Infectious Diseases, Jiangsu Key Laboratory for Molecular Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.

Department of Infectious Diseases, Second Hospital of Nanjing, Southeast University, Nanjing, Jiangsu, China.

出版信息

JHEP Rep. 2023 Jun 29;5(11):100831. doi: 10.1016/j.jhepr.2023.100831. eCollection 2023 Nov.

DOI:10.1016/j.jhepr.2023.100831
PMID:37791377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10542634/
Abstract
摘要